665 related articles for article (PubMed ID: 35327979)
21. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.
Catanesi M; d'Angelo M; Tupone MG; Benedetti E; Giordano A; Castelli V; Cimini A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825273
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in glaucoma and neurodegenerative diseases.
Molasy M; Walczak A; Szaflik J; Szaflik JP; Majsterek I
J Hum Genet; 2017 Jan; 62(1):105-112. PubMed ID: 27412874
[TBL] [Abstract][Full Text] [Related]
24. Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.
Vasconcelos CFM; Ribas VT; Petrs-Silva H
Cells; 2023 Aug; 12(17):. PubMed ID: 37681887
[TBL] [Abstract][Full Text] [Related]
25. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
26. New insights into the role of microRNAs and long noncoding RNAs in most common neurodegenerative diseases.
Maniati MS; Maniati M; Yousefi T; Ahmadi-Ahangar A; Tehrani SS
J Cell Biochem; 2019 Jun; 120(6):8908-8918. PubMed ID: 30663117
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs: novel therapeutic targets in neurodegenerative diseases.
Roshan R; Ghosh T; Scaria V; Pillai B
Drug Discov Today; 2009 Dec; 14(23-24):1123-9. PubMed ID: 19822222
[TBL] [Abstract][Full Text] [Related]
28. The role of microRNAs in neurodegenerative diseases: a review.
Li S; Lei Z; Sun T
Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
[TBL] [Abstract][Full Text] [Related]
29. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA in central nervous system trauma and degenerative disorders.
Liu NK; Xu XM
Physiol Genomics; 2011 May; 43(10):571-80. PubMed ID: 21385946
[TBL] [Abstract][Full Text] [Related]
31. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
32. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
[TBL] [Abstract][Full Text] [Related]
33. Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases.
You HJ; Park JH; Pareja-Galeano H; Lucia A; Shin JI
Neuromolecular Med; 2016 Dec; 18(4):540-550. PubMed ID: 27209362
[TBL] [Abstract][Full Text] [Related]
34. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
35. The involvement of microRNAs in neurodegenerative diseases.
Maciotta S; Meregalli M; Torrente Y
Front Cell Neurosci; 2013 Dec; 7():265. PubMed ID: 24391543
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs (miRNAs) in neurodegenerative diseases.
Nelson PT; Wang WX; Rajeev BW
Brain Pathol; 2008 Jan; 18(1):130-8. PubMed ID: 18226108
[TBL] [Abstract][Full Text] [Related]
37. A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease.
Szelągowski A; Kozakiewicz M
Oxid Med Cell Longev; 2023; 2023():7759053. PubMed ID: 37333462
[TBL] [Abstract][Full Text] [Related]
38. Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases.
Li D; Li YP; Li YX; Zhu XH; Du XG; Zhou M; Li WB; Deng HY
Chin Med J (Engl); 2018 Sep; 131(18):2216-2225. PubMed ID: 30203797
[TBL] [Abstract][Full Text] [Related]
39. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.
Abdelmaksoud NM; Sallam AM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Al-Noshokaty TM; Elrebehy MA; Elshaer SS; Mahmoud NA; Fathi D; Rizk NI; Elballal MS; Mohammed OA; Abdel-Reheim MA; Zaki MB; Saber S; Doghish AS
Pathol Res Pract; 2024 Jan; 253():155007. PubMed ID: 38061270
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets.
Liu S; Fan M; Zheng Q; Hao S; Yang L; Xia Q; Qi C; Ge J
Biomed Pharmacother; 2022 Apr; 148():112681. PubMed ID: 35177290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
